- Trials with a EudraCT protocol (89)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
89 result(s) found for: Maternal complications of pregnancy.
Displaying page 1 of 5.
| EudraCT Number: 2021-000994-96 | Sponsor Protocol Number: 214725 | Start Date*: 2021-07-14 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A Phase III, double-blind, randomized, placebo-controlled study to evaluate the safety, reactogenicity and immune response of a single intramuscular dose of unadjuvanted RSV Maternal vaccine, in hi... | ||
| Medical condition: High risk pregnant women (prevention of RSV-associated lower respiratory tract illnesses (LRTIs) in infants) | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | |
| Trial protocol: FI (Completed) ES (Temporarily Halted) IT (Completed) Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000535-23 | Sponsor Protocol Number: HCB/2021/0060 | Start Date*: 2022-06-20 | |||||||||||
| Sponsor Name:Barcelona Institute for Global Health (ISGlobal) | |||||||||||||
| Full Title: Efficacy of low dose acetylsalicylic acid in preventing adverse maternal and perinatal outcomes in SARS-CoV-2 infected pregnant women | |||||||||||||
| Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-004444-31 | Sponsor Protocol Number: KWMP001 | Start Date*: 2015-01-09 |
| Sponsor Name: | ||
| Full Title: Effects and consequences for mother and child from treatment for depression A prospective randomized, placebo- controlled, trial with internet-based cognitive behavior therapy and sertraline or... | ||
| Medical condition: Prosepctive randomized two armed study to evaluate moderate depression during pregnancy treated with interbnetbased CBT and sertarline or placebo and longterm outcome in the children.Secondary obj... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003220-31 | Sponsor Protocol Number: 54463 | Start Date*: 2016-06-21 |
| Sponsor Name:VU medical center, Amsterdam | ||
| Full Title: Low dose aspirin in the Prevention of Recurrent Spontaneous Preterm Labour – the APRIL study | ||
| Medical condition: Prevention of recurrent spontaneous preterm birth | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002640-23 | Sponsor Protocol Number: APHP200003 | Start Date*: 2020-12-14 |
| Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS | ||
| Full Title: Effect of increased oxytocin doses on the mode of delivery in obese primiparous women with spontaneous labour. A double-blind, randomised, controlled trial | ||
| Medical condition: To compare the rates of caesarean section in obese patients with spontaneous labour between two oxytocin dosage regimens | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004160-58 | Sponsor Protocol Number: CHASAP | Start Date*: 2021-06-11 | ||||||||||||||||
| Sponsor Name:Centre hospitalier intercommunal de Créteil | ||||||||||||||||||
| Full Title: Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled trial | ||||||||||||||||||
| Medical condition: Pregnant women with chronic hypertension | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: FR (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2020-002135-30 | Sponsor Protocol Number: NCT04379973 | Start Date*: 2021-04-28 |
| Sponsor Name:Antwerp University Hospital (UZA) | ||
| Full Title: Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel group pragmatic trial in infertile women with at least one pate... | ||
| Medical condition: Infertility defined as lack of conception despite 12 months of unprotected intercourse, or three cycles of donor insemination without pregnancy or three ovulatory ovulation induction cycles without... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003410-12 | Sponsor Protocol Number: RG_19-169 | Start Date*: 2020-12-16 |
| Sponsor Name:University of Birmingham | ||
| Full Title: Pregnancy ANtihypertensive Drugs: which Agent is best? | ||
| Medical condition: Hypertension in pregnancy (chronic hypertension, gestational hypertension or pre-eclampsia) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005444-35 | Sponsor Protocol Number: C4591015 | Start Date*: 2021-04-15 | |||||||||||
| Sponsor Name:BioNTech SE | |||||||||||||
| Full Title: A PHASE 2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID-19 IN HEAL... | |||||||||||||
| Medical condition: Protection against COVID-19 | |||||||||||||
|
|||||||||||||
| Population Age: In utero, Under 18, Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-001936-45 | Sponsor Protocol Number: matab4 | Start Date*: 2011-05-25 |
| Sponsor Name: | ||
| Full Title: Pertussis vaccination in pregnancy | ||
| Medical condition: The number of reported pertussis cases is rising, also in very young infants. Different strategies are possible to close the gap of susceptibility between the loss of maternal antibodies and prote... | ||
| Disease: | ||
| Population Age: In utero, Newborns, Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001850-83 | Sponsor Protocol Number: 2012/175/HP | Start Date*: 2013-08-02 | |||||||||||
| Sponsor Name:CHU- Hôpitaux de Rouen | |||||||||||||
| Full Title: Adaptation to neonatal life after an anesthetic protocol using remifentanil for general anesthesia for caesarean section in a context of prematurity - REAGI Protocol (Remifentanil for General Anes... | |||||||||||||
| Medical condition: pregnant woman older than 18 years with an indication for caesarean section under general anesthesia in a context of prematurity. | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-003778-29 | Sponsor Protocol Number: CTU/2013/064 | Start Date*: 2014-01-30 | |||||||||||
| Sponsor Name:University College London | |||||||||||||
| Full Title: Combined Multi-Marker Screening and Randomised Patient Treatment with Aspirin for Evidence-based Pre-eclampsia Prevention | |||||||||||||
| Medical condition: Pre-eclampsia | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) IT (Completed) BE (Completed) GR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-000789-13 | Sponsor Protocol Number: Trial_version1 | Start Date*: 2013-07-05 | |||||||||||
| Sponsor Name:VU University Medical Center | |||||||||||||
| Full Title: Vitamin D And Lifestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention - A European multicentre, randomised trial: Vitamin D limb. | |||||||||||||
| Medical condition: Gestational diabetes | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: AT (Completed) BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-005811-34 | Sponsor Protocol Number: 24d005 | Start Date*: 2018-07-05 |
| Sponsor Name:VU Medical Center, Amsterdam | ||
| Full Title: Pregnancy reLated Acute hyperTension INtervention Action: a randomized trial comparing labetalol and nicardipine in women with acute hypertension in pregnancy (Platina-trial) | ||
| Medical condition: To asses optimal treatment of hypertension of hypertensive disorders in pregnancy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003138-18 | Sponsor Protocol Number: UCC-Strider | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:University College Cork | |||||||||||||
| Full Title: STRIDER Ireland: A Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early‐Onset Intrauterine Growth Restriction | |||||||||||||
| Medical condition: Severe early - onset Intrauterine Growth Restriction (IUGR), (also referred to as Fetal growth restriction) diagnosed between 22+0 and 29+6 gestational age. IUGR is defined as an estimated fetal we... | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
| Trial protocol: IE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-001878-42 | Sponsor Protocol Number: viagra01 | Start Date*: 2018-03-27 | ||||||||||||||||
| Sponsor Name:CONSORCIO HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA | ||||||||||||||||||
| Full Title: Sildenafil Citrate effect on in vivo human trophoblast research. | ||||||||||||||||||
| Medical condition: This is a placebo – controlled longitudinal study to determine whether maternal administration of an unique oral dose of sildenafil citrate (50mg) improves placental flow in first trimester in ... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2017-004866-86 | Sponsor Protocol Number: P160944J | Start Date*: 2020-01-23 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Evaluation of the benefit of adjuvant treatment with hydroxychloroquine to usual medical care for uncomplicated term pregnancy in patients with primary obstetrical antiphospholipid syndrome: random... | |||||||||||||
| Medical condition: Primary obstetrical antiphospholipid syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-001244-38 | Sponsor Protocol Number: 14SM1971 | Start Date*: 2014-07-16 | |||||||||||
| Sponsor Name:Imperial College London | |||||||||||||
| Full Title: Preventing Recurrent Gestational Diabetes Mellitus with Early Metformin Intervention | |||||||||||||
| Medical condition: Gestational diabetes mellitus. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-000419-34 | Sponsor Protocol Number: RC15_0475 | Start Date*: 2016-10-24 | |||||||||||
| Sponsor Name:CHU de Nantes | |||||||||||||
| Full Title: | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-000811-26 | Sponsor Protocol Number: STOPPRE | Start Date*: 2018-09-19 | |||||||||||
| Sponsor Name:Vall D'Hebron Institut de Recerca (VHIR) | |||||||||||||
| Full Title: A phase III, multicentric, Randomized, open-label, parallel-group clinical trial to detect false positives from first-trimester preeclampsia screening (StopPRE) at the second-trimester of pregnancy. | |||||||||||||
| Medical condition: First-trimester pre-eclampsia patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.